Delhi, July 2026: In a heartening story of hope, timely decision-making, and the promise of stem cell preservation, a young child diagnosed with thalassaemia major has moved towards a healthier future after undergoing a successful stem cell transplant using preserved newborn stem cells from his younger sibling. The case highlights the growing role Cryoviva Life Sciences plays in supporting Indian families through newborn stem cell banking.

Mantra’s Thalassaemia Major Diagnosis and Early Treatment Challenges

Mantra, the family’s elder son, was diagnosed with thalassaemia major at just two-and-a-half months of age. Since then, his life depended on regular blood transfusions – a routine that became both emotionally and physically challenging for the family. Over time, repeated transfusions also resulted in iron overload, making iron chelation therapy an essential part of his ongoing treatment.

Like many parents facing such a difficult diagnosis, Mantra’s family continued searching for a long-term solution. After consulting medical specialists and speaking with other families, they learnt that a stem cell transplant could offer a potentially curative treatment option for eligible patients with thalassaemia. However, a successful transplant requires a suitably matched donor.

Why the Family Chose Cryoviva Life Sciences for Newborn Stem Cell Preservation

When the family’s younger child was born, the parents made the important decision to preserve his newborn stem cells with Cryoviva Life Sciences, hoping they might one day support Mantra’s treatment journey. This decision – rooted in awareness of stem cell banking benefits – later became a turning point for the family. Learn more about Newborn Stem Cell Banking with Cryoviva Life Sciences

The Stem Cell Transplant Journey with Cryoviva Life Sciences

When the appropriate time came, Mantra underwent a stem cell transplant using the preserved stem cells stored with Cryoviva Life Sciences, along with freshly collected stem cells from his younger sibling. This combination of preserved and fresh stem cells gave doctors the matched material needed for the procedure.

Expert Insight: Cryoviva Life Sciences’ Medical Director on the Case

Speaking about the case, Dr. Aditi Kundoo, Medical Director, Cryoviva Life Sciences, said:

“Stories like Mantra’s reinforce our belief in the long-term value of newborn stem cell preservation. For families affected by serious conditions such as thalassaemia, preserved stem cells can become an important medical resource when clinically appropriate. We are grateful to have played a supportive role in this family’s journey and remain committed to helping parents make informed decisions for their children’s future.”

Life After Transplant: A New Beginning for Mantra

Today, Mantra no longer requires regular blood transfusions or iron chelation therapy, marking a life-changing milestone for him and his family. His journey serves as a powerful reminder of how awareness, timely medical guidance, and stem cell preservation with Cryoviva Life Sciences can together create new possibilities for families living with thalassaemia. Read more about Thalassaemia and Stem Cell Transplants

Cryoviva Life Sciences’ Message to Parents

The family hopes their experience will encourage other parents, particularly those with a child affected by thalassaemia, to explore newborn stem cell preservation with Cryoviva Life Sciences and discuss suitable treatment options with qualified medical professionals. About Cryoviva Life Sciences

Frequently Asked Questions

What is thalassaemia major?

Thalassaemia major is a severe inherited blood disorder that typically requires regular blood transfusions and, in eligible cases, can be treated with a stem cell transplant.

How does newborn stem cell preservation help in thalassaemia treatment?

Preserved newborn stem cells, especially from a matched sibling, can be used in a stem cell transplant as a potentially curative option for eligible thalassaemia patients.

Why do families choose Cryoviva Life Sciences for stem cell banking?

Cryoviva Life Sciences supports families through newborn stem cell preservation, helping create a potential medical resource for future treatment needs, as seen in Mantra’s case.